SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-19-000039
Filing Date
2019-11-07
Accepted
2019-11-07 16:46:12
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20190930x10q.htm 10-Q 1522611
2 EX-31.1 plse-20190930xex31_1.htm EX-31.1 22338
3 EX-31.2 plse-20190930xex31_2.htm EX-31.2 22548
4 EX-32.1 plse-20190930xex32_1.htm EX-32.1 19458
  Complete submission text file 0001625101-19-000039.txt   5252098

Data Files

Seq Description Document Type Size
5 EX-101.INS plse-20190930.xml EX-101.INS 1010802
6 EX-101.SCH plse-20190930.xsd EX-101.SCH 35941
7 EX-101.CAL plse-20190930_cal.xml EX-101.CAL 50796
8 EX-101.DEF plse-20190930_def.xml EX-101.DEF 136044
9 EX-101.LAB plse-20190930_lab.xml EX-101.LAB 317127
10 EX-101.PRE plse-20190930_pre.xml EX-101.PRE 275092
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 191201034
SIC: 3841 Surgical & Medical Instruments & Apparatus